MARTELL RON — SEC Form 4 filings

SEC reporting owner CIK 1177079. 6 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-02-20 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Jasper Therapeutics, Inc. (JSPR)President, CEO and Director, Director61 leg · 41,000 sh · $99,6307

Form 4 filings — MARTELL RON

FiledFormIssuerReported transactionsSource
2026-01-054Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 234,000 (derivative) @ $0EDGAR
2025-09-244Jasper Therapeutics, Inc. (JSPR)Purchase (P): 41,000 @ $2.43 · Purchase (P): 41,000 (derivative)EDGAR
2025-06-064Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 234,000 (derivative) @ $0EDGAR
2025-02-184Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 130,000 (derivative) @ $0EDGAR
2024-06-124Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2024-02-204Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 100,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1177079 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →